ANIMATION

Idiopathic Pulmonary Fibrosis and the Effects of Treatment

Share this animation:

About 50,000 people in the United States are diagnosed with IPF each year. After diagnosis, the estimated survival is only 3 years. Patients with IPF deteriorate to the extent that most die of respiratory failure; essentially their lungs can’t get enough oxygen into their blood.

The animation, developed in partnership with Wedgewood Communications, shows the mechanism of disease for IPF and the mechanism of action for the recently-approved agent OFEV (nintedanib) from Boehringer Ingelheim.

The 6.5-minute animation shows in great detail how the lungs work to get oxygen into the blood, how the lung tissue is repaired when damage occurs, and how this repair process goes awry in IPF.

Share It:
Contact XVIVO

Client


Idiopathic Pulmonary Fibrosis and the Effects of Treatment

My experience working with XVIVO can be summed up in one word: Confidence. Confidence in what the quality of the final animation would be, as well as confidence in their recommendations in regard to executing the animation from the initial pre-production meetings throughout the life of the project, until the final delivery. Confidence from the very first day that they would do what they said, when they said they would do it, and deliver high quality multimedia on time, and on budget.

VP, Director of Production, JUICE Pharma Advertising
Share this animation: